Bolivia's health ministry. Through its Programa Nacional de Lucha Contra el Cáncer it applies the 2019 cancer law, keeps the national cancer registry and runs the free Sistema Único de Salud for people without social insurance.
Ley 1223 del Cáncer of 5 September 2019 makes the Ministry of Health the authority that applies the law through its Programa Nacional de Lucha Contra el Cáncer, from surveillance and prevention to treatment and palliative care, and requires it to run the Registro Nacional de Cáncer, to which every public, social insurance and private facility must report. Decreto Supremo 4881 of 22 February 2023 regulates the law: it sets the membership of the National Cancer Commission that the law created, chaired by the minister, with the programme as its technical secretariat, and asks the programme to write the registry's manuals. The coordinates are an approximate La Paz city point.
The Ministry also runs the Sistema Único de Salud (SUS), created by Ley 1152 of 20 February 2019, which gives Bolivians not covered by social security free care in public facilities, reached by referral from a first-level health centre; the cancer law adds cancer care to the SUS progressively. In October 2026 the Ministry reported more than 103,500 new cancers and more than 31,500 cancer deaths in the national registry for 2016 to 2025, and launched Consultorios Rosa with Roche Bolivia for earlier breast cancer diagnosis among women aged 40 to 60 in the SUS.
Its essential medicines list for 2026 to 2027, kept by AGEMED, includes 41 antineoplastic medicines and 10 hormone treatments for cancer. Cervical screening reached about 14% of women aged 20 to 69 in 2022, according to a nationwide study.
Palliative care has grown in Bolivia over two decades, and the review finds gaps across every WHO pillar, including access to opioids and the places care is offered.
Bolivia is far from WHO's target of 70% screening coverage, and the gaps are geographical, which shows where the screening programme most needs strengthening.
A resource for finding who among the many people with gallstones in the Andes should have their gallbladder removed before cancer develops; Bolivia, with GLOBOCAN's highest estimated gallbladder cancer rate, contributes about one participant in seven.
The authors conclude that Bolivia's high rate of cervical cancer is not explained by more HPV infection than elsewhere, and that testing on site, with results in about an hour, avoids the very long waits for screening results in Bolivia.
Evidence for moving Bolivian screening beyond the Pap smear, toward HPV self-sampling and visual inspection that can be done close to home.
An early population-based picture of cancer in Bolivia, already showing the high cervical and gallbladder cancer rates that IARC's estimates show today; OnCo found no current population-based registry in the country.
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO).
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/